Navigation Links
Leading Clinical Technology Organization M2S Inc. Announces the Appointment of Jeffrey Yablon as Senior Vice President, Business Development
Date:4/15/2009

M2S Inc., a clinical technology organization providing image management services for biopharmaceutical and medical device clinical trials and clinical data registries, announced today that it has named Jeffrey Yablon as its new Senior Vice President, Business Development. In his new role at M2S, Mr. Yablon will be responsible for managing all M2S sales efforts and overseeing the marketing strategy of the rapidly expanding Clinical Trials Imaging, endovascular, and Clinical Data Registries services, in addition to the development and implementation of strategic partnerships.

(PRWEB) April 15, 2009 -- M2S Inc., a clinical technology organization providing image management services for biopharmaceutical and medical device clinical trials and clinical data registries, announced today that it has named Jeffrey Yablon as its new Senior Vice President, Business Development.

Mr. Yablon brings over 20 years of experience in the life sciences industry, including senior management roles in pharmaceuticals, drug safety, laboratory management, clinical research, medical imaging and clinical technology. Before joining M2S, Mr. Yablon held the position of Vice President, Sales and Marketing with Sciformix Corporation, a knowledge process outsourcing organization providing pharmacovigilance services to biopharmaceutical and biotech companies. Prior to that position, he held the position of Vice President of Global Business Development at Perceptive Informatics, the technology division of Parexel International. He was also Chief Operating Officer at ICON Laboratories, a division of ICON Plc. Mr. Yablon is a founder of several companies as well as a current instructor and course director at Stony Brook University, Center for Biotechnology in Stony Brook, NY. He began his career at TAP Pharmaceuticals and Abbott Laboratories, where he held various positions of increasing responsibility in sales and marketing. Mr Yablon received his MBA from the executive program at Fairleigh Dickinson University. In his new role at M2S, Mr. Yablon will be responsible for managing all M2S sales efforts and overseeing the marketing strategy of the rapidly expanding Clinical Trials Imaging, Endovascular, and Clinical Data Registries services, in addition to the development and implementation of strategic partnerships.

"Jeffrey has extensive experience and in-depth industry knowledge of the clinical research and informatics industry, and therefore will be a great asset to our organization," said M2S's CEO, Wes Chapman. "He is a well respected and established leader in the clinical trials community, and our clients will greatly benefit from his understanding of their drug and medical device challenges in the new economy. His leadership, combined with the M2S clinical expertise, highly efficient processes and advanced technologies, will continue to advance our market share in the clinical trials and patient data registries markets."

Mr. Yablon says, "I am excited to be part of a truly differentiated Clinical Technology Organization that is able to combine best-in-class technical infrastructure with superior clinical acumen that will directly impact cost, quality, and efficiency to benefit our clients. I look forward to playing a key role in the growth of M2S."

About M2S
M2S is a Clinical Technology Organization (CTO), providing high-quality, timely and cost-effective image data management services for clinical trial sponsors in the biopharmaceutical and medical device industries as well as clinical registry databases. For the past 10 years, M2S has managed, under protocol, over 150 million images from around the globe in all major therapeutic areas and in all DICOM modalities. For more information, visit www.m2s.com

###

Read the full story at http://www.prweb.com/releases/clinical/trials/prweb2324234.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Frost & Sullivan Recognizes CRi for Innovations Leading to Personalized Medicine
2. Western Governors University to Launch Nations First Competency-Based B.S. in Nursing Leading to RN Licensure
3. HealthEquity, a Leading Healthcare Account Administrator, Licenses Thomson Reuters Information Solutions to Help People Make Better Healthcare Decisions
4. Nobel Prize Winner Professor Muhammad Yunus Leading Delegation From Bangladesh to World Health Care Congress to Advance Affordable Health Care Innovations
5. Global Med Technologies(R), Inc. Licenses Its Leading European Blood and Laboratory Solutions to Homburg, Germany Clinic Blood Center
6. New head-to-head clinical studies reveal Reach Ultraclean toothbrush and floss deliver superior plaque removal compared to leading competitive products
7. The Nation's Leading Health Care Strategy Firm Launches Post-Merger Integration Practice
8. Versus Technology to Showcase Leading Enterprise Patient and Clinical Workflow Solutions at HIMSS 2009
9. Last step leading to blood cell formation elucidated
10. Leading Autism Care Provider Invites MPs to Meet Residents and Staff for World Autism Awareness Day
11. Streamline Health to Deliver Hosted Document Workflow Solution to Leading West Coast University-Affiliated Surgery Department
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Leading Clinical Technology Organization M2S Inc. Announces the Appointment of Jeffrey Yablon as Senior Vice President, Business Development
(Date:2/12/2016)... ... 2016 , ... The law firm of Morrow, Morrow, Ryan & Bassett is ... these scholarships is to encourage applicants to pursue a degree in their field of ... parishes. , “We have available jobs in St. Landry and Evangeline Parishes that ...
(Date:2/12/2016)... ... February 12, 2016 , ... ... — 1:30 p.m. – 3:00 p.m. EST, http://www.fdanews.com/fixeddosecombination ... cycle of pharmaceutical products, garnering increased attention from all stakeholders in the development ...
(Date:2/12/2016)... , ... February 12, 2016 , ... ... announced that nominations have closed for the ISE Southeast Awards 2016. Finalists and ... announced at the ISE® Southeast Executive Forum and Awards Gala on March 15, ...
(Date:2/12/2016)... ... February 12, 2016 , ... Fisher House Foundation Chairman and CEO Kenneth Fisher ... Military Support Alliance president Scott Bensing, and Peggy Kearns Director, VA Southern Nevada Healthcare ... System. This will be the first Fisher House in Nevada, and will provide ...
(Date:2/12/2016)... ... February 12, 2016 , ... Erlanger Agency has announced a new partnership in ... latest campaign focuses on the fight against breast cancer, fundraising for a local woman ... here . , Carmen is a loving single mother of two boys who also ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... Stem cells are primitive cells found in all multi-cellular ... to differentiate into mature cell types Stem cells are ... embryonic stem cells were derived from embryos in 1981, ... culturing of embryonic stem cells from non-human primates occurred ... As a result of these discoveries, stem cells can ...
(Date:2/11/2016)... 2016  Kindred Biosciences, Inc. (NASDAQ: KIN ), ... lives of pets, today announced the submission to FDA ... Drug Application (NADA) for Zimeta™ (dipyrone injection, KIND-012).  Positive ... Zimeta for the control of pyrexia (fever) in horses ... --> --> The Chemistry, Manufacturing, and ...
(Date:2/11/2016)...   Health 2.0 , the premiere showcase and ... today " 10 Year Global Retrospective ", a platform ... past ten years.   --> ... has served as the preeminent thought-leader in the health ... technologies, companies, innovators, and patient-activists through an array of ...
Breaking Medicine Technology: